Zetta Genomics
The Genome Optimised Data Store: Enabling healthcare transformation using big data technology
Zetta Genomics
The Genome Optimised Data Store: Enabling healthcare transformation using big data technology
TL;DR
What they do: Build XetaBase, a genomic-native platform for managing and querying population-scale genomic data
Headquarters: Cambridge, UK (additional office in Valencia, Spain)
Founded: 2017–2018 (spinout from University of Cambridge and Genomics England)
Employees: ~30
Total funding: £6.2M (multiple seed rounds; latest Feb 8, 2024)
Company Overview
Problem Domain
Genomic data management, indexing, querying and interpretation at population scale to enable precision medicine and research.
Founded
2018
Industry
Genomics / Health-tech
Funding Track Record
£2,500,000
Seed funding reported in 2022 (~£2.5M) per company materials
£1,900,000
Second seed round led by Nina Capital with participation from APEX Ventures and Cambridge Enterprise
Latest seed round recorded on Feb 8, 2024; Crunchbase lists We Venture Capital among recent investors
Investor Signal
“Backed by specialized health-tech investors including Nina Capital, APEX Ventures, Cambridge Enterprise and We Venture Capital”